Charles River Laboratories International Inc (NYSE:CRL) currently has a daily average trading volume of 1.57M but it saw 247085 shares traded in last market. With a market cap of 7.72B USD, the company’s current market price of $157.12 came falling about -0.23 while comparing to the previous closing price of $157.49. In past 52 weeks, the stock remained buoying in the range of price level as high as $254.15 and as low as $91.86. In the recent trading on the day, stock has struck highest price mark of $156.1655 while lowest mark touched by it was $158.72.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Redburn Atlantic which upgraded the stock as “Buy” in its note to investors issued on May 23, 2025, recommending a price target of $182 for it. TD Cowen upgraded its recommendation for the stock as a “Buy” from “Hold” on May 14, 2025 while assigning a price target of $179. Evercore ISI also issued its recommendations for the stock as it upgraded the price target for the stock is $170.
Over the week, CRL’s stock price is moving 3.65% up while it is 13.45% when we observe its performance for the past one month. Year-to-date it is -22.69% down and over the past year, the stock is showing a downside performance of -14.89%.
Currently, Charles River Laboratories International Inc’s total number of outstanding shares is 49.12M. Company’s return on investment (ROI) stands at -0.51% and return on equity (ROE) at -0.92%. It has a 15.22 of forward P/E ratio. Stock’s beta reads 1.47. Stock has a price to book (P/B) ratio of 2.42 while price to sale or P/S ratio amounts to 1.92. Its return on asset (ROA) is -0.40% on average.
